· 12hPhilip Morris International beats earnings estimates on strong ZYN demand
Cigarette maker Philip Morris International posted better-than-expected fourth quarter results, driven by strong demand for its smoking alternatives such as ZYN nicotine pouches, sending its shares up nearly 8% on Thursday.
Federal health officials have authorized the marketing and sale of Zyn nicotine pouches, marking the first time the Food and Drug Administration authorized these popular products that go between a ...
Q4 2024 Management View CEO Jacek Olczak highlighted that 2024 marked an "outstanding performance," with record achievements in adjusted diluted EPS, operating cash flow, and smoke-free product growth ...
Zyn, which delivers nicotine to the bloodstream ... For Aedan, a less harmful source changed the cost-benefit analysis of nicotine use. “I smoked and vaped intermittently in college and more ...
Packets of Zyn cost around $5 and have names including Bellini or Citrus, which critics have said encourages young people to buy them. Marketing campaigns for the pouches have focused on ...
Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris International, which faced a yearslong decline in cigarette smoking.
The U.S. Food and Drug Administration (FDA) recently approved the marketing of 20 Zyn nicotine pouches, marking the first time nicotine pouches have received such authorization. This decision came ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback